rugada syndrome is a sudden cardiac death syndrome 1-3 that has the specific electrocardiographic (ECG) features of J-point elevation and ST-segment elevation, which are believed to result from a disturbance of the Na channel in the myocardium. 4 Normally, these typical ECG features are transient, but the contributory factors to their development remain unclear.
rugada syndrome is a sudden cardiac death syndrome [1] [2] [3] that has the specific electrocardiographic (ECG) features of J-point elevation and ST-segment elevation, which are believed to result from a disturbance of the Na channel in the myocardium. 4 Normally, these typical ECG features are transient, but the contributory factors to their development remain unclear.
We describe a case of transient Brugada syndrome-like ST-segment elevation that was exacerbated by nausea and vomiting.
Case Report
The patient was a 53 year-old male who had been hospitalized for the treatment of syncope 3 times in the preceding 6 months. The cause of his symptoms was not apparent and consequently a cardiac origin was investigated. The ECG on admission exhibited a normal axis, slight prolongation of the QRS width (0.12 s), slight ST segment elevation (0.1 mV) suggestive of early repolarization in the right precordial leads, normal QT interval, and no ischemic ST-T changes. These ECG findings did not change under normal conditions and both Holter ECG monitoring and echocardiography revealed normal cardiac function. The treadmill test revealed horizontal ST-segment depression in leads II, III, aVF, V5 and V6, which suggested ischemic heart disease. Cardiac catheterization demonstrated a 75% stenosis of the mid portion of the right coronary artery, and normal left and right ventriculography. Acetylcholine administration into the coronary arteries (50 g and 100 g of ACh in the right and left coronary arteries, respectively) induced spasm (a stenosis of 50%) in the posterior descending and left anterior descending arteries. However, there were no changes recorded on the ECG during ACh administration. Percutaneous transluminal coronary angioplasty of the right coronary artery was successful.
An electrophysiological study (EPS) was performed 1 week later in which ventricular fibrillation (VF) was repeatedly induced by the ventricular extrastimulus method (2 paired extrastimuli). Intravenous pilsicainide (1 mg/kg) was followed by slight elevation of the J-point and STsegment in the right precordial leads, which suggested that Brugada syndrome was responsible for the VF (Fig 1) . Five min later, the subject experienced severe nausea and vomited twice during which the ECG showed an increased elevation of the J-point and ST-segment (Fig 2) . These ECG changes recovered to normal 30 mins later; the nausea and vomiting improved after the second vomiting episode. One week later, pilsicainide administration (1 mg/kg) was repeated (Fig 3) , and the J-point and ST-segment slightly elevated, but nausea and vomiting did not occur. The ECG changes improved 30 min after the administration of pilsicainide without any further significant J-point or STsegment elevation.
An implantable cardioverter defibrillator (ICD) was implanted and a calcium channel blocker was prescribed. A tilt test (60°tilting) was performed 1 week after the ICD implantation and neither blood pressure nor heart rate changed significantly during either the control state or with isoproterenol administration. For 10 months, the patient has been free of both syncopal episodes and VF.
The patient gave informed consent for all investigations and therapies.
Discussion
The cause of the syncope experienced by the present patient was strongly suspected to be related to VF associated with Brugada syndrome. However, arrhythmia related to ( The STsegment was not elevated during these heart beats, which we believe is related to the influence of posture change on the relative location between the electrodes and the heart.) coronary artery disease was also suspected, which is why we prescribed a calcium channel blocker in conjunction with ICD implantation. The underlying mechanism of the J-point and ST-segment elevation in Brugada syndrome is believed to be related to a transmural repolarization gradient in the right ventricle, based on an imbalance between the outward and inward currents (ie, outward > inward) 5 that is affected by sodium channel blockers and vagal activity. 6 An interesting aspect of the present case was the particular type of J-point and ST-segment elevation (ie, typical Brugada syndrome-like ECG morphology; coved type STsegment elevation) that was induced when the patient felt nauseous and vomited. We propose that this phenomenon originated from a strong autonomic change. Sympathetic stimulation decreases ST-segment elevation, 6, 7 whereas it is believed that vagal stimulation contributes to ST-segment elevation and the occurrence of VF. 6, 8 We also propose that the ECG changes originated from the vagal stimulation associated with the nausea and vomiting, because significant ECG changes were not observed during the second pilsicainide administration trial in which those symptoms did not occur. Though the cause of the nausea and vomiting is unknown, the symptoms completely and quickly improved without any treatment.
To the best of the our knowledge, this is the first report of Brugada syndrome-like ECG changes induced by nausea and vomiting.
